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Abstract
We introduce a probabilistic generative model for disentangling spatio-temporal disease
trajectories from collections of high-dimensional brain images. The model is based on spatio-
temporal matrix factorization, where inference on the sources is constrained by anatomically
plausible statistical priors. To model realistic trajectories, the temporal sources are defined as
monotonic and time-reparameterized Gaussian Processes. To account for the non-stationarity
of brain images, we model the spatial sources as sparse codes convolved at multiple scales.
The method was tested on synthetic data favourably comparing with standard blind source
separation approaches. The application on large-scale imaging data from a clinical study
allows to disentangle differential temporal progression patterns mapping brain regions key
to neurodegeneration, while revealing a disease-specific time scale associated to the clinical
diagnosis.
Keywords: Alzheimer’s disease, Disease progression modeling, Gaussian Process, Bayesian
modeling, Stochastic variational inference, Clinical trials
1. Introduction
Neurodegenerative disorders such as Alzheimer’s disease (AD) are characterized by morpho-
logical and molecular changes of the brain, ultimately leading to cognitive and behavioral
decline. Clinicians suggested hypothetical models of the disease evolution, showing how
different types of biomarkers interact and lead to the final dementia stage [15]. In the past
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years, efforts have been made in order to collect large databases of imaging and clinical
measures, hoping to obtain more insights about the disease progression through data-driven
models describing the trajectory of the disease over time. This kind of models are of critical
importance for understanding the pathological progression in large scale data, and would
represent a valuable reference for improving the individual diagnosis.
Current clinical trials in AD are based on longitudinal monitoring of biomarkers. Dis-
ease progression modelling aims at providing an interpretable way of modelling the evolution
of biomarkers according to an estimated history of the pathology, as proposed for example in
[10], [12], [16], [23], and [41]. Therefore, disease progression models are promising methods
for automatically staging patients, and quantifying their progression with respect to the
underlying model of the pathology. These approaches entail a great potential for automatic
stratification of individuals based on their estimated stage and progression speed, and for
assessment of efficacy of disease modifying drugs. Within this context, we propose a spatio-
temporal generative model of disease progression, aimed at disentangling and quantifying
the independent dynamics of changes observed in datasets of multi-modal data. With this
term we indicate data acquired via different imaging modalities such as Magnetic Resonance
Imaging (MRI) or Positron-Emission Tomography (PET), as well as non-imaging data such
as clinical scores assessed by physicians. Moreover, we aim at automatically inferring the
disease severity of a patient with respect to the estimated trajectory. Defining such a disease
progression model raises a number of methodological challenges.
AD spreads over decades with a temporal mismatch between the onset of the disease and the
moment where the clinical symptoms appear. Either age of diagnosis, or the chronological
age, are therefore not suitable as a temporal reference to describe the disease progression in
time. Moreover, as the follow-up of patients doesn’t exceed a few years, the development of
a model of long-term pathological changes requires to integrate cross-sectional data from
different individuals, in order to consider a longer period of time. In virtue of the lack of a
well defined temporal reference, observations from different individuals are characterized by
large and unknown variability in the onset and speed of the disease. It is therefore necessary
to account for a time-reparameterization function, mapping each individuals’ observations to
a common temporal axis associated to the absolute disease trajectory [16, 36]. This would
allow to estimate an absolute time-reference related to the natural history of the pathology.
The analysis of MRI and PET data, requires to account for spatio-temporally correlated
features (voxels, i.e. volumetric pixels) defined over arrays of more than a million entries.
The development of inference schemes jointly considering these correlation properties thus
raises scalability issues, especially when accounting for the non-stationarity of the image
signal. Furthermore, the brain regions involved in AD exhibit various dynamics in time,
and evolve at different speed [39]. From a modeling perspective, accounting for differential
trajectories over space and time raises the problem of source identification and separation.
This issue has been widely addressed in neuroimaging via Independent Component Analysis
(ICA) [8], especially on functional MRI (fMRI) data [7]. Nevertheless, while fMRI time-series
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are usually defined over a few hundreds of time points acquired per subject, our problem
consists in jointly analyzing short-term and cross-sectional data observations with respect
to an unknown time-line. This problem cannot be tackled with standard ICA, as time is
generally an independent variable on which inference is not required. Moreover, ICA retrieves
spatial sources based on the assumption of statistical independence. This assumption does
not necessarily lead to clinically interpretable findings. Indeed, dependency across temporal
patterns can be still highly relevant to the pathology, for example when modeling temporal
delay across similar sources.
The problem of providing a realistic description of the biological processes is critical when
analyzing biomedical data, such as medical images. For example, to describe a plausible evo-
lution of AD from normal to pathological stages, smoothness and monotonicity are commonly
assumed for the temporal sources. It is also necessary to account for the non-stationarity of
changes affecting the brain from global to localized spatio-temporal processes. As a result,
spatial sources need to account for different resolutions at which these changes take place.
While several multi-scale analysis approaches have been proposed to model spatio-temporal
signals [26, 6, 14], extending this type of methods to the high-dimension of medical images is
generally not trivial due to scalability issues. Finally, the noisy nature of medical images,
along with the large signal variability across observations, requires a modeling framework
robust to bias and noise.
In this work, we propose to jointly address these issues within a Bayesian framework
for the spatio-temporal analysis of large-scale collections of multi-modal brain data. We
show that this framework allows us to naturally encode plausibility constraints through
clinically-inspired priors, while accounting for the uncertainty of the temporal profiles and
brain structures we wish to estimate. Similarly to the ICA setting, we formulate the problem
of trajectory modeling through matrix factorization across temporal and spatial sources.
This is done for each modality by inferring their specific spatio-temporal sources. To promote
smoothness in time and avoid any unnecessary hypothesis on the temporal trajectories, we
rely on non-parametric modeling based on Gaussian Process (GP). We account for a plausible
evolution from healthy to pathological stages thanks to a monotonicity constraint applied on
the GP. Moreover, individuals’ observations are temporally re-aligned on a common scale
via a time-warping function. In case of imaging data, to model the non-stationarity of
the spatial signal, the spatial sources are defined as sparse activation maps convolved at
different scales. We show that our framework can be efficiently optimized through stochastic
variational inference, allowing to exploit automatic differentiation and GPU support to speed
up computations.
The paper is organized as follows: Section 2 analyzes related work on spatio-temporal
modeling of neurodegeneration, while Section 3 details our method. In Section 4 we present
experiments on synthetic data in which we compare our model to standard blind source
separation approaches. We finally provide a demonstration of our method on the modeling
of imaging data from a large scale clinical study. Prospects for future work and conclusions
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are drawn in section 5. Derivations that we could not fit in the paper are detailed in the
Appendices.
2. Related Work in Neurodegeneration Modeling
To deal with the uncertainty of the time-line of neurodegenerative pathologies, the concept
of time-reparameterization of imaging-derived features has been used in several works. The
underlying principle consists in estimating an absolute time-scale of disease progression by
temporally re-aligning data from different subjects. For instance, in [42] the time-evolution
was approximated as a sequence of events which need to be re-ordered for each patient.
This approach thus considers the evolution of neurodegenerative diseases as a collection of
transitions between discrete stages. This hypothesis is however limiting, as it doesn’t reflect
the continuity of changes affecting the brain along the course of the pathology.
To address this limitation, we rely on a continuous parameterization of the time-axis as in
[23, 10]. In particular, individuals’ observations are time-realigned on a common temporal
scale via a time-warping function. Using a set of relevant scalar biomarkers, this kind of
approach allows to learn a time-scale describing the pathology evolution, and to estimate a
data-driven time-line markedly correlated with the decline of cognitive abilities. Similarly,
in [4] a disease progression score was estimated using biomarkers from molecular imaging.
These methods are however based on the analysis of low-dimensional measures, such as
collections of clinical variables. Therefore, they do not allow to scale to the high dimension
of multi-modal medical images. Our work tackles this shortcoming thanks to a scalable
inference scheme based on stochastic variational inference.
Concerning the spatio-temporal representation of neurodegeneration, a mixed-effect model
was proposed by [21] to learn an average spatio-temporal trajectory of brain evolution on
cortical thickness data. The fixed-effect describes the average trajectory, while random
effects are estimated through individual spatio-temporal warping functions, modeling how
each subject differs from the global progression. Still, the extension of this approach to
image volumes raises scalability issues. It has also to be noted that, to allow computational
tractability, the brain evolution was assumed to be stationary both in space and time, thus
limiting the ability of the model to disentangle the multiple dynamics of the brain structures
involved in AD.
An attempt to source separation is proposed in [27], through the decomposition of cor-
tical thickness measurements as a mixture of spatio-temporal processes. This is performed
by associating to each cortical vertex a temporal progression modeled by a sigmoid function,
which may be however too simplistic to describe the progression of AD temporal processes.
We propose to overcome this issue by non-parametric modeling of the temporal sources
through GPs. Moreover, the model in [27] is lacking of an explicit vertex-wise correlation
model, as it only assumes correlation between clustering parameters at the resolution of the
mesh graph. For this reason, it may still be sensitive to spatial variation at different scales
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and noise. We address this problem by modeling the spatial sources through convolution
of sparse maps at multiple resolutions, allowing to deal with signal non-stationarity and
robustness to noise.
3. Methods
In the following sections a matrix will be denoted by an uppercase letter X, its n-th row
will be given by Xn: and its n-th column by X :n. A column vector will be denoted by a
lowercase letter x. Subscript indices will be used to index the elements of matrices, vectors
or sets of scalars. Superscipt indices will allow to index the blocks of block diagonal matrices.
3.1. Individual time-shift
To account for the uncertainty of the time-line of individual measurements, we assume
that the observations are defined with respect to an absolute temporal reference τ . This
is performed through a time-warping function tp = f p(τ), that models the individual
time-reparameterization. We choose an additive parameterization such that:
f p(τ) = τ + δp. (1)
Within this setting the individual time-shift δp encodes the temporal position of subject p,
which in our application can be interpreted as the disease stage of subject p with respect to
the long-term disease trajectory. We denote by δ = {δp}Pp=0 the set of time-shift parameters.
3.2. Data modeling
We represent the spatio-temporal data D by a block diagonal matrix in which we differenti-
ate two main blocks Y and V as illustrated in Figure 1. Each sub-block Y m is a matrix
containing the data represented by one of the M imaging modalities we wish to consider.
These matrices have dimensions P ×Fm, where P denotes the number of subjects and Fm the
number of imaging features for modality m, which in our case is the number of voxels. The
matrix V accounts for non-imaging or scalar data such as clinical scores and has dimensions
P × C, where C is the number of scalar features considered. We postulate a generative
model and decompose the data as shown in Figure 1. For each sub-block Y m, the data is
factorized in a set of Nm spatio-temporal sources Y
m = SmAm. The columns of the matrix
Sm describe the non-linear temporal evolution of the corresponding spatial maps contained
in the rows of Am. Therefore, their product represents the voxel-wise linear combination
of the spatial maps modulated by the corresponding temporal sources. The subjects share
the same set of temporal sources across S1, ..,SM , as these sources describe the temporal
evolution of the group-wise images through the regression problem specified in Figure 1. The
data in matrix V is modelled by a matrix U whose columns depict the temporal trajectories
of the different scalar scores. In the case of imaging data, we also consider a constant term
modeling brain areas which don’t exhibit any intensity changes over time. This is done
by including constant matrix terms Zm that we need to estimate. We assume for a given
modality m that the vectors Zmp: are common to every subjects. Finally, for each modality
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Figure 1: Spatio-temporal decomposition of each data block. A data matrix composed by M imaging
modalities is decomposed as the product of monotonic temporal sources Sm and corresponding activation
maps Am. Monotonic sources are also used to model the scalar biomarkers V , while we assume additive
constant terms Zm, and noise Em.
m, scalar score c, and subject p, we assume Gaussian observational noise Emp: ∼ N (0, σ2mI),
and Hp,c ∼ N (0, ν2c ) for respectively imaging and scalar information.
Therefore, if we consider the data from modality m and scalar c of patient p observed at
time f p(τ) we have:
Y mp: (f p(τ), θm, ψm) = S
m
p: (f p(τ), θm)A
m(ψm) +Z
m
p: + Emp: ,
V p,c(f p(τ), θc) = U p,c(f p(τ), θc) +Hp,c.
(2)
We denote by θm and θc the temporal parameters related respectively to the modality m
and scalar feature c, while ψm represents the set of spatial parameters of modality m. We
assume conditional independence across modalities and scalar scores given the time-shift
information:
p(Y ,V |A,S,Z,U , δ, σ, ν) =
(∏
m
p(Y m|Am,Sm,Zm, δ, σm)
)(∏
c
p(V :c|U :c, δ, νc)
)
. (3)
Relying on classical regression formulation, we assume exchangeability across subjects allowing
us to derive the data likelihood for a given modality m. According to the generative model
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we can write:
p(Y m|Am,Sm,Zm, δ, σm) =
(∏
p
1
(2piσ2m)
Fm
2
exp(− 1
2σ2m
||Y mp: (f p(τ), θm, ψm)
− Smp: (f p(τ), θm)Am(ψm)−Zmp: ||2)
)
.
(4)
Naturally, a similar equation holds for p(V :c|U :c, δ, νc).
Within a Bayesian modeling framework, we wish to maximize the marginal log-likelihood
log(p(Y ,V |Z, δ, σ, ν)), to obtain posterior distributions for the spatio-temporal processes.
Since the derivation of this quantity in a closed-form is not possible, we tackle this optimiza-
tion problem through stochastic variational inference. Based on this formulation, in what
follows we illustrate our model by detailing the variational approximations imposed on the
spatio-temporal sources, along with the priors and constraints we impose to represent the
data (Sections 3.3 and 3.4). Finally, we detail the variational lower bound and optimization
strategy in Section 3.5.
For ease of notation we will drop the m and c indexes in Sections 3.3 and 3.4. As a result
the matrix S will indistinctly refer to either any Sm or U , while matrix A will refer to any
Am, and Y to any Y m. For a given modality m, the number of patients P will be indexed
by p, the number of sources Nm or the number of scalar scores C will be indexed by n, and
finally f will index the number of imaging features Fm.
3.3. Spatio-temporal processes
3.3.1. Temporal sources
In order to flexibly account for non-linear temporal patterns, the temporal sources are
encoded in a matrix S in which each column S:n is a GP representing the evolution of
source n and is independent from the other sources. To allow computational tractability
within a variational setting, we rely on the GP approximation proposed in [9], through kernel
approximation via random feature expansion [32]. Within this framework, a GP can be
approximated as a Bayesian Neural Network with form: S:n(t) = φ(t(ω
n)T )wn. For example,
in the case of the Radial Basis Function (RBF) covariance, ωn is a linear projection in the
spectral domain. It is equipped with a Gaussian distributed prior p(ωn) ∼ N (0, lnI) with a
zero-mean and a covariance parameterized by a scalar ln, acting as the length-scale parameter
of the RBF covariance. The non-linear basis functions activation is defined by setting
φ(·) = (cos(·), sin(·)), while the regression parameter wn is given with a standard normal
prior. The GP inference problem can be conveniently performed by estimating approximated
variational distributions for all the ωn and wn (Section 3.5). We will respectively denote by
Ω and W the block diagonal matrices whose blocks are the (ωn)T and wn. Considering the
N temporal sources, we can write p(Ω) =
∏
n p(ω
n) and p(W ) =
∏
n p(w
n).
We wish also to account for a steady evolution of the temporal processes, hence constraining
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the temporal sources to monotonicity. This is relevant in the medical case, where one would
like to model the steady progression of a disease from normal to pathological stages. In
our case, we want to constrain the space of the temporal sources to the set of solutions
Cn = {S:n(t) | S′:n(t) ≥ 0 ∀ t}. This can be done done consistently within the regression
setting of [33], and in particular with the GP random feature expansion framework as shown
in [22]. In that work, the constraint is introduced as a second likelihood term on the temporal
sources dynamics:
p(C|S′, γ) =
∏
p,n
(1 + exp(−γS′p,n(t)))−1, (5)
where S′ contains every derivatives S′:n, γ controls the magnitude of the monotonicity
constraint, and C = ⋂n Cn. According to [22] this constraint can be specified through the
parametric form for the derivative of each S:n:
S′:n(t) =
dφ(t(ωn)T )
dt
wn. (6)
This setting leads to an efficient scheme for estimating the temporal sources through stochastic
variational inference (Section 3.5).
3.3.2. Spatial sources.
According to the model introduced in Section 3.2, each observation Y p: is obtained as the
linear combination at a specific time-point between the temporal and spatial sources. In
order to deal with the multi-scale nature of the imaging signal, we propose to represent
the spatial sources at multiple resolutions. To this end, we encode the spatial sources
in a matrix A whose rows An: represent a specific source at a given scale. The scale is
prescribed by a convolution operator Σn, which is a applied to a map Bn: that we wish
to infer. This problem can be specified by defining An: = Bn:Σ
n, where Σn is an F × F
Gaussian kernel matrix imposing a specific spatial resolution. The length-scale parameter
λn of the Gaussian kernel is fixed for each source, to force the model to pick details at
that specific scale. Due to the high-dimension of the data we are modeling, performing
stochastic variational inference in this setting raises scalability issues. For instance, if we
assume a Gaussian distribution N (µBn: , diag(Λ)) for Bn:, the distribution of the spatial
signal would be p(An:) ∼ N (µBn:Σn,Σndiag(Λ)(Σn)T ). As a result, sampling from p(An:)
is not computationally tractable due to the size of the covariance matrix, which prevents the
use of standard inference schemes on Bn:. This can be overcome thanks to the separability of
the Gaussian convolution kernel [28, 25], according to which the 3D convolution matrix Σn
can be decomposed into the Kronecker product of 1D matrices, Σn = Σnx ⊗Σny ⊗Σnz . This
decomposition allows to efficiently perform standard operations such as matrix inversion,
or matrix-vector multiplication [35]. Thanks to this choice, we recover tractability for the
inference of Bn: through sampling, as required by stochastic inference methods [20].
3.4. Sparsity
In order to detect specific brain areas involved in neurodegeneration, we propose to introduce
a sparsity constraint on the maps (or codes) Bn:. Consistently with our variational inference
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scheme, we induce sparsity via Variational Dropout as proposed in [19]. This approach
leverages on an improper log-scale uniform prior p(|Bn:|) ∝
∏
f 1/|Bn,f |, along with an
approximate posterior distribution:
q1(B) =
N∏
n=1
N (Mn:, diag(αn,1M 2n,1...αn,FM 2n,F )). (7)
In this formulation, the dropout parameter αn,f is related to the individual dropout probability
pn,f of each weight by αn,f = pn,f(1 − pn,f)−1. When the parameter αn,f exceeds a fixed
threshold, the dropout probability pn,f is considered high enough to ignore the corresponding
weight Mn,f by setting it to zero. However, this framework raises stability issues affecting
the inference of the dropout parameters due to large-variance gradients, thus limiting pn,f to
values smaller than 0.5. To tackle this problem, we leverage on the extension of Variational
Dropout proposed in [29]. In this setting, the variance parameter is encoded in a new
independent variable P n,f = αn,fM
2
n,f , while the posterior distribution is optimized with
respect to (M ,P ). Therefore, in order to minimize the cost function for large variance
P n,f →∞ (αn,f →∞ i.e pn,f → 1), the value of the weight’s magnitude must be controlled
by setting to zero the corresponding parameter Mn,f . As a result, by dropping out weights
in the code, we sparsify the estimated spatial maps, thus better isolating relevant spatial
sub-structures. Spatial correlations in the images are obtained thanks to the convolution
operation detailed in Section 3.3.2.
3.5. Variational inference
We detailed in the previous sections the choices of priors and constraints that we apply to
the spatio-temporal processes in order to plausibly model the data. To illustrate the overall
formulation of the method, we provide in Figure 2 the graphical model over the M modalities
in the case of imaging data. Naturally, this graph simplifies when we deal with scalar data
as we don’t need to account for any spatial dependence. To infer the time-shift parameter δ,
the sets of parameters θm, θc, and ψm, as well as Z, σ and ν, we need to jointly optimize the
data evidence according to priors and constraints:
log(p(Y ,V , C|Z, δ, σ, ν, γ)) =
∑
m
log(p(Y m, Cm|Zm, δ, σm, γm)) +
∑
c
log(p(V :c, Cc|δ, νc, γc)).
(8)
We tackle the optimization of Equation (8) via stochastic variational inference. Following [9]
and [22] we introduce approximations, q2(Ω
m) and q3(W
m) in addition to q1(B
m) in order
to derive a lower bound Lm for each modality. We recall that the temporal trajectories
Sm and U are treated similarly as described in Section 3.3.1. We also note that the choice
of distributions q1, q2 and q3 is the same across modalities, while their parameters will be
9
δ
Figure 2: Graphical model for imaging data, Y = {Y m}.
inferred independently. This leads to:
log(p(Y m, Cm|Zm, δ, σm, γm)) >Eq1,q2,q3 [log(p(Y m|Bm,Ωm,Wm,Zm, δ, σm))]
+ Eq2,q3 [log(p(Cm|Ωm,Wm, δ, γm))]
−D[q1(Bm)||p(Bm)]−D[q2(Ωm)||p(Ωm)]−D[q3(Wm)||p(Wm)],
log(p(V c:, Cc|δ, νc, γc)) >Eq2,q3 [log(p(V c:|Ωc,W c, δ, σc))]
+ Eq2,q3 [log(p(Cc|Ωc,W c, δ, γc))]
−D[q2(Ωc)||p(Ωc)]−D[q3(W c)||p(W c)]
(9)
Where D refers to the Kullback-Leibler (KL) divergence. Combining the lower bounds of the
different modalities we obtain:
log(p(Y ,V , C|Z, δ, σ, ν, γ)) >
∑
m
Lm +
∑
c
Lc. (10)
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A detailed derivation of the lower bound is given in Appendix A.
The approximated distributions q2(Ω
m) and q3(W
m) are factorized across GPs such that:
q2(Ω
m) =
Nm∏
n=1
q2(ω
n)m =
Nm∏
n=1
Nrf∏
j=1
N (Rn,j,Q2n,j)m,
q3(W
m) =
Nm∏
n=1
q3(w
n)m =
Nm∏
n=1
Nrf∏
j=1
N (T n,j,V 2n,j)m,
(11)
where Nrf is the number of random features used for the projection in the spectral domain.
Using Gaussian priors and approximations we introduced above, we can obtain a closed-form
formula for the KL divergence. Moreover, the choice of prior and approximate posterior distri-
bution for the maps of Bm leads to an approximation for the divergence D[q1(Bm)||p(Bm)]
detailed in [29]. This allows to analytically compute all the KL terms in our cost function.
Formulas for the KL divergences are detailed in Appendix B.
Finally, we optimize the individual time-shifts δ = {δp}Pp=0, Z, σ = {σm}Mm=1, ν = {νc}Cc=1
as well as the overall sets of spatio-temporal parameters θ = {θm}Mm=1 ∪ {θc}Cc=1 and
ψ = {ψm}Mm=1.
θ = {Rmn:,Qmn:,Tmn:,V mn:, ln, n ∈ [1, Nm]}Mm=1 ∪ {Rc:,Qc:,T c:,V cc:, lc}Cc=1,
ψ = {Mmn:,Pmn:, n ∈ [1, Nm]}Mm=1.
(12)
Following [20] and using the reparameterization trick, we can efficiently sample from the
approximated distributions q1, q2 and q3 to compute the two expectation terms from (9)
for each modality. We chose to alternate the optimization between the spatio-temporal
parameters and the time-shift. We set γm to the minimum value that gives monotonic sources.
This was done through multiple tests on data batches with different numbers of imaging
features Fm and sources Nm. We empirically found that monotonicity was enforced when the
magnitude of γm was in the order of Fm ×Nm. The threshold for the dropout probability
above which we set a weight Bmn,f to zero was fixed at 95% (i.e α = 19), while the σm and
νm were optimized during training along with the spatio-temporal parameters. The model is
implemented and trained using the Pytorch library [30]. The complete experimental setting is
detailed in Appendix C. We also provide a pseudo-code detailing the optimization procedure
in Appendix D. In the following sections we will refer to our method as Monotonic Gaussian
Process Analysis (MGPA).
4. Experiments and Results
In this section we first benchmark MGPA on synthetic data to demonstrate its reconstruction
and separation properties while comparing it to standard sources separation methods. We
finally apply our model on a large set of medical data from a publicly available clinical study,
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demonstrating the ability of our method to retrieve spatio-temporal processes relevant to
AD, along with a time-scale describing the course of the disease.
4.1. Synthetic tests on spatio-temporal trajectory separation
For the synthetic tests we considered the case where the data is associated to a single imaging
modality only. We tested MGPA on synthetic data generated as a linear combination of
temporal functions and 3D activation maps at prescribed resolutions. The goal was to assess
the method’s ability to identify the spatio-temporal sources underlying the data. We bench-
marked our method with respect to ICA, Non-Negative Matrix Factorization (NMF), and
Principal Component Analysis (PCA), which were applied from the standard implementation
provided in the Scikit-Learn library [31].
The benchmark was specified by defining a 10-folds validation setting, generating the data
at each fold as a linear combination of temporal sources S˜(t) = [S˜:0(t), S˜:1(t)], and spatial
maps A˜ = [A˜0:, A˜1:]. The data was defined as Y p: = S˜p:(tp)A˜+ Ep: over 50 time points tp,
where tp was uniformly distributed in the range [0, 0.7], and Ep: ∼ N (0, σ2I). The temporal
sources were specified as sigmoid functions S˜p,i(tp) = 1/(1 + exp(−tp +αi)), while the spatial
structures had dimensions (30 × 30 × 30) such that A˜i: = B˜i:Σ˜i. The Σ˜i were chosen as
Gaussian convolution matrices with respective length-scale of λ = 2 mm and λ = 1 mm. The
B˜i: were randomly sampled sparse 3D maps.
Variable selection. We applied our method by specifying an over-complete set of six
sources with respective spatial length-scale of λ = {2, 2, 1, 1, 0.5, 0.5 mm}. Figure 3 shows an
example of the sparse maps obtained for a specific fold. The model prunes the signal for most
of the maps, while retaining two sparse maps, B0: and B4:, whose length-scale are λ = 2
mm and λ = 1 mm, thus correctly estimating the right number of sources and their spatial
resolution. As it can be qualitatively observed in Figure 3, we notice that the estimated
sparse code convolved with a Gaussian kernel matrix with λ = 1 mm is closer to its ground
truth than the one convolved with a length-scale λ = 2 mm. According to our tests, sparse
codes associated to high resolution details (low λ) are indeed more identifiable. On the
contrary, the identifiability of images obtained via a convolution operator with larger kernels
(large λ) is lower, since these maps can be equivalently obtained through the convolution of
different sparse codes.
Sources separation. We observe in Table 1 that the lowest Mean-Squared Error (MSE) for
the temporal sources reconstruction is obtained by MGPA, closely followed by ICA. Similarly,
our model and ICA show the highest Structural Similarity (SSIM) score [38], which quantifies
the image reconstruction accuracy with respect to the ground truth maps, while accounting
for the inter-dependencies between neighbouring pixels. An example of image reconstruction
from a sample fold is illustrated in Figure 4. In this standard benchmark, we note that
MGPA leads to comparable results with respect to the state of the art. In the following
section, we compare the models in the more challenging setting in which the time-line has to
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Figure 3: Slices extracted from the six sparse codes and the ground truth. Blue: Rejected points. Yellow:
Retained points.
be estimated as well.
Table 1: MSE and SSIM between respectively the ground truth temporal and spatial sources with respect to
the ones estimated by the different methods.
Temporal (MSE) Spatial (SSIM)
MGPA (8± 4).10−5 98%± 1
ICA (6± 3).10−4 97%± 2
NMF (3± 2).10−2 40%± 17
PCA 0.44± 10−3 15%± 1
4.2. Synthetic tests on trajectory separation and time-reparameterization
In this test, we modify the experimental benchmark by introducing a further element of
variability associated to the time-axis. The temporal and spatial sources were modelled
following the same procedure as in Section 4.1, however the observations were mixed along
the temporal axis. To do so we generated longitudinal data as Y p,j,: = S˜p:(t)A˜ + Ej:, by
sampling between 1 and 10 images per time-point and randomly re-arranging them along
the time-axis (cf. time-shift tp of each observation at initialization in Figures 5 and 6, panel
“Time-Shift”). The goal was to assess the sources separation performances of MGPA when
the time-line is unknown. The experiment was run on 10 folds and Figures 5 and 6 illustrate
the sources estimation for two different folds. We present these two figures to demonstrate
how the time-shift inference affects the temporal sources reconstruction. Since the model
is agnostic of a time-scale, we note that the time-shift may have a different range than the
13
MGPA mapsICA maps
MGPA
Temporal sources
MGPA
0 21
Maps Intensity
S0Ground Truth
S1
Spatial maps
A0
A1
Figure 4: Spatio-temporal reconstruction when inference on the time-line is not required. Spatial maps:
Sample slice from ground truth images (A0 λ = 2 mm, A1 λ = 1 mm), the maps estimated by ICA, and
the ones estimated by MGPA. Temporal sources: Ground truth temporal sources (red) along with sources
estimated by ICA (green) and MGPA (blue).
original time-axis. However, its relative ordering should be consistent with the original time
points. We fitted a linear regression model over the 10 folds between the original time and
the estimated time-shift parameter, and obtained an average R2 coefficient of 0.98 with a
standard deviation of 0.005 (cf. Table 2). This is illustrated for two different folds in the
Table 2: MSE and SSIM between respectively the ground truth temporal and spatial sources with respect to
the ones estimated by MGPA. R2 coefficient of the linear regression between the original time-line and the
estimated time-shift.
Temporal (MSE) Spatial (SSIM) R2
MGPA (2± 0.8).10−2 95%± 4 0.98± 0.005
Time-Shift panel of Figures 5 and 6, where we observe a strong linear correlation with the
original time-line, meaning that the algorithm correctly re-ordered the data with respect to
the original time-axis. However, we notice in Table 2 that the MSE of the temporal sources
significantly increased, due to the additional difficulty brought by the time-shift estimation.
Indeed, in order to reconstruct the temporal signal we need to perfectly re-align hundreds
of observations. This is the case in Figure 5 (optimal reconstruction result), where the
time-shift is highly correlated with the original time-line, allowing to distinguish every single
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observation and reconstruct the original temporal profiles. Whereas in Figure 6 (sub-optimal
reconstruction result), the estimated time-shift doesn’t exhibit a perfect fit, and generally
underestimates the time-reparameterization for the later and earlier time points. This is
related to the challenging setting of reconstructing the time-line identified by the original
temporal sources. Indeed, we observe that S:0 reaches a plateau for early time points, while
S:1 is flat for later ones. This behaviour increases the difficulty of differentiating time points
with low signal differences. As a result, it impacts the time-shift optimization and adds
variability to the time-shift estimation performances, thus deteriorating the reconstruction of
the temporal sources over the 10 folds compared to the previous benchmark. The spatial
sources estimation remains comparable to the one without time-shift both quantitatively,
with an average SSIM of 95%, and qualitatively, as shown in Figures 5 and 6. Within this
setting, ICA, NMF and PCA poorly perform as they can’t reconstruct the time-line. Results
obtained using these three methods are provided in Appendix E.
Time-Shift tpGround Truth
MGPA maps S0
0 21
Maps Intensity
MGPA
MGPA
Spatial maps Temporal sources Time-Shift
S1
A0
A1
Figure 5: Spatio-temporal reconstruction when inference on the time-line is required. Optimal reconstruction
result. Spatial maps: Sample slice from ground truth images (A0 λ = 2 mm, A1 λ = 1 mm) and estimated
spatial sources. Temporal sources: In red the original temporal sources, in blue the estimated temporal
sources. Time-Shift: Time-shift tp of each image at initialization (top), and after estimation (bottom). In
blue, linear fit with the ground truth.
4.3. Application to spatio-temporal brain progression modeling
4.3.1. Data processing
Data used in the preparation of this article were obtained from the Alzheimers Disease
Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). The ADNI was launched in
2003 as a public-private partnership, led by Principal Investigator Michael W. Weiner, MD.
For up-to-date information, see www.adni-info.org.
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Figure 6: Spatio-temporal reconstruction when inference on the time-line is required. Sub-optimal recon-
struction result. Spatial maps: Sample slice from ground truth images (A0 λ = 2 mm, A1 λ = 1 mm) and
estimated spatial sources. Temporal sources: In red the original temporal sources, in blue the estimated
temporal sources. Time-Shift: Time-shift tp of each image at initialization (top), and after estimation
(bottom). In blue, linear fit with the ground truth.
We selected a cohort of 544 amyloid positive subjects of the ADNI database composed
of 103 controls (NL), 164 Mild Cognitive Impairment (MCI), 114 AD patients, 34 healthy
individuals converted to MCI or to AD (NL converter) and 129 MCI converted to AD
(MCI converter). The term amyloid positive refers to subjects whose amyloid level in the
cerebrospinal fluid (CSF) is below the nominal cutoff of 192 pg/ml. Conversion to MCI or
AD was determined using the last follow-up available information. We provide in Table 3
socio-demographic and clinical information across the different groups.
MRI, FDG-PET and AV45-PET of each individual were processed in order to obtain
respectively, volumes of gray matter density, glucose uptake, and amyloid load in a standard
anatomical space.
MRI processing protocol. Baseline MRI images were analyzed according to the SPM12
processing pipeline [2]. Each image was initially segmented into grey, white matter and CSF
probabilistic maps. Grey matter images were used for the following analysis, normalized to a
group-wise reference space via DARTEL [1], and modulated using the Jacobian determinant
of the subject-to-template transformation. The subsequent modeling was carried out on the
normalised images at the original spatial resolution.
PET processing protocol. Individuals' baseline PET images were initially affinely aligned
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Table 3: Baseline socio-demographic and clinical information for study cohort. Average values and standard
deviation in parenthesis. NL: normal individuals, NL converter: normal subjects who converted to MCI or to
AD, MCI: mild cognitive impairment, MCI converter: MCI subjects who converted to AD, AD: Alzheimer’s
patients. ADAS13: Alzheimer’s Disease Assessment Scale-cognitive subscale, 13 items. FAQ: Functional
Assessment Questionnaire. FDG: (18)F-fluorodeoxyglucose Positron Emission Tomography (PET) imaging.
AV45: (18)F-florbetapir Amyloid PET imaging.
Group NL
NL
converter
MCI
MCI
converter
AD
N 103 34 164 129 114
Age 73 (6) 78 (5) 73 (7) 73 (7) 74 (8)
Education (yrs) 16.3 (3) 16 (3) 15.7 (3) 16 (3) 15.6 (3)
ADAS13 9.1 (4.4) 11.4 (4.3) 14.6 (5.5) 20.4 (6.5) 31.6 (8.5)
FAQ 0.3 (0.7) 0.2 (0.6) 1.9 (2.8) 5.0 (4.6) 13.5 (6.9)
Entorhinal (cm3) 3.8 (0.5) 3.5 (0.5) 3.6 (0.6) 3.2 (0.7) 2.8 (0.6)
Hippocampus (cm3) 7.4 (0.9) 6.9 (0.7) 6.9 (0.9) 6.4 (0.9) 5.9 (0.8)
Ventricles (cm3) 31 (16) 42 (21) 39 (23) 40 (19) 48 (23)
Whole brain (cm3) 1033 (104) 1019 (91) 1058 (103) 1037 (102) 1005 (115)
FDG 1.3 (0.1) 1.3 (0.1) 1.2 (0.1) 1.1 (0.1) 1.0 (0.1)
AV45 1.3 (0.2) 1.3 (0.1) 1.3 (0.2) 1.4 (0.2) 1.5 (0.2)
to the corresponding MRI. After scaling the intensities to the cerebellum, the images were
normalized to the grey matter template obtained with DARTEL and smoothed with a FWHM
parameter of 4.55.
Images have dimension 102 × 130 × 107 before vectorization, leading to 1, 418, 820 spa-
tial features per patient. These spatial features represent for each voxel their gray matter
concentration in the case of MRI images, their glucose metabolism for FDG-PET images, or
their amyloid concentration for AV45-PET images. To exploit the ability of our model to
automatically adapt to different spatial scales, we chose to keep the MRI images at their
native resolution for the analysis, and thus do not perform additional smoohting to equalize
to the PET FWHM. In addition to the imaging data of each patient, we also integrate the
ADAS13 score assessed by clinicians. High values of this score indicate a decline of cognitive
abilities. We consider three matrices Y MRI , Y FDG, and Y AV 45 of dimension (543×1, 418, 820)
containing the images of all the subjects, and a matrix V of dimension (543× 1) containing
their ADAS13 score. From now on we will refer to the data as the block diagonal matrix
containing the four matrices Y MRI ,Y FDG, Y AV 45, and V as described in Section 3.2. We
note that the analysis is performed by only considering a single scan per imaging modality
and ADAS13 score for each patient. Therefore, the temporal evolution has to be inferred
solely through the analysis of relative differences between the brain morphologies, glucose
metabolisms, amyloid concentrations and cognitive abilities across individuals.
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4.3.2. Model specification
We aim at showing how MGPA applied on the data extracted from the ADNI cohort is
able to temporally re-align patients in order to describe AD progression in a plausible way,
while detecting relevant spatio-temporal processes at stake in AD. The model estimates
AD progression by relying on MR, FDG-PET, AV45-PET scans and ADAS13 score of each
patient. The temporal sources SMRI and SFDG associated respectively to the loss of gray
matter, and to the decrease of glucose uptake, are enforced to be monotonically decreasing.
On the contrary, the temporal sources SAV 45 and U :ADAS13, modeling respectively the
evolution of amyloid concentration, and ADAS13 score, are enforced to be monotonically
increasing. Since we don’t consider any information about the disease stage of each individual
before applying our method, all the observations are initialized at the same time reference
τ = 0. Therefore, as for the tests in Section 4.2, the time-shift reparameterization describes
a relative re-ordering of the subjects not related to a specific time-unit. To decompose the
imaging data we apply our model by specifying an over-complete basis of six sources with
λ = {8, 8, 4, 4, 2, 2 mm}, to cover both different scales and the associated variety of temporal
evolution. Due to the high-dimension of the data matrix, the computations were parallelized
over six GPUs, and the model required eighteen hours to complete the training. Details on
the model convergence during training are provided in Appendix F.
4.3.3. Estimated spatio-temporal brain dynamics
In Figure 7 we show the spatio-temporal processes retained by the model for each imaging
modality. Interestingly, the model adapts to the spatial resolution of MRI and PET images.
Indeed, we notice that the model accounts for the high-resolution of MRI images by retaining
a source associated to the lowest length-scale (λ = 2 mm). Concerning PET data, we observe
that the induced sparsity discards the highest resolution codes (λ = 2 mm) for both FDG and
AV45, highlighting the ability of the model to adapt to the coarser resolution of the PET signal.
In the case of MRI data, two sources were retained at two different resolutions (λ = 4
mm and λ = 2 mm). Source SMRI4 describes gray matter loss encompassing a large extent
of the brain with a focus on cortical areas (see AMRI4 ). We note that this map also targets
subcortical areas such as the hippocampi, which are key regions of AD. Source SMRI2 (λ = 4
mm) indicates a mild decrease of gray matter which accelerates in the latest stages of the
disease, and targets the temporal poles (see AMRI2 ). It is interesting to notice that this
differential pattern of gray matter loss also affects the parahippocampal region, whose atrophy
is known to be prominent in AD [11]. These results underline the complex evolution of
brain atrophy, and the ability of the model to disentangle spatio-temporal processes mapping
different regions involved in the pathology [3, 13]. Concerning the spatio-temporal processes
extracted from the FDG-PET data, we see on Figure 7 that the model retained two sources
at the coarsest resolutions (λ = 8 mm). Source SFDG1 indicates a pattern of hypometabolism
that tends to plateau and which involves most of the brain regions, thus describing a global
effect of the pathology on the glucose uptake. Source SFDG0 describes a linear pattern of
hypometabolism targeting areas such as the precuneus and the parietal lobe, which are
known to be strongly affected during the evolution of the disease [5]. Finally, the model
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extracted two spatio-temporal sources from the AV45-PET data at two different resolutions
(λ = 8 mm and λ = 4 mm). We observe that source SAV 452 highlights an increase of amyloid
deposition mapping a large extent of the brain, such as the parietal and frontal lobes as well
as temporal areas, thus concurring with clinical evidence [34]. Similarly to the FDG-PET
processes, we have a source SAV 450 exhibiting a differential pattern of amyloid deposition
targeting mostly frontal, temporal, occipital areas and precuneus.
The estimated spatio-temporal processes can be combined to obtain an estimated evo-
lution SmAm of the brain along the time-shift axis for each modality. In Figure 8, we show
the ratio |Smp:Am − Sm0:Am|/Sm0:Am between the image predicted at four time-points tp and
the image predicted at t0 for the three imaging modalities. This allows us to visualize the
trajectory of a brain going from a healthy to a pathological state in terms of atrophy, glucose
metabolism and amyloid load according to our model.
Finally, we also applied ICA, NMF and PCA on the ADNI data, showing that the as-
sociated results are characterized by poor interpretability and high variability. The complete
experimental setting and results are detailed in Appendix G.
4.3.4. Model Consistency
To verify the plausibility of the fitted model, we compare in Figure 9 the concentration
predicted by the model and the raw concentration measures in different brain areas for the
three imaging modalities. We observe a decrease of gray matter and glucose metabolism as
we progress along the estimated time-line, allowing to relate large time-shift values to lower
gray matter density and glucose uptake. Moreover, we notice the agreement between the
predictions made by the model (in blue) and the raw concentration measures (in red). In the
case of AV45 data there is only a mild increase of amyloid load according to the model, prob-
ably due to the fact that the subjects selected in the cohort are already amyloid positive. As
a result, they already show a high baseline amyloid level concentration, close to plateau levels.
In Figure 10, we show the estimated GP U :ADAS13. We observe that the model is able
to plausibly describe the evolution of this cognitive score, while demonstrating a larger
variability than in the case of imaging modalities.
4.3.5. Plausibility with respect to clinical evidence
We assessed the clinical relevance of the estimated time-shift by relating it to independent
medical information which were not included in the model during training. To this end,
we compared the estimated time-shift to ADAS11, MMSE and FAQ scores. High values of
ADAS11 and FAQ or low values of MMSE indicate a decline of performances. We show in
Figure 11 that the estimated time-shift correlates with a decrease of cognitive and functional
abilities. In particular, a cubic model slightly better describes the relationship between
ADAS11 and the time-shift (according to BIC and AIC), with a significance for the cubic
coefficient of p = 0.04. Concerning MMSE and FAQ, quadratic and linear models were
almost equivalent; the significance of the linear coefficients was p < 0.01, while the quadratic
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Figure 7: Estimated spatio-temporal processes for the three imaging modalities. The time-scale was re-scaled
to the arbitrary range [0, 1].
Figure 8: Ratio between the model prediction at time tp and the prediction at t0 for the three imaging
modalities. The time-scale was re-scaled to the arbitrary range [0, 1].
coefficient was never significant. Pearson correlation coefficients for ADAS11, FAQ and
MMSE were respectively of 0.49, 0.41, and −0.45, with corresponding p-values p < 0.01.
The box-plot of Figure 12 shows the time-shift distribution across clinical groups. We
observe an increase of the estimated time-shift when going from healthy to pathological
stages. The high uncertainty associated to the MCI group is due to the broad definition of
this clinical category, which includes subjects not necessarily affected by dementia. We note
that MCI subjects subsequently converted to AD (MCI converter) exhibit higher time-shift
than the clinically stable MCI group, highlighting the ability of the model to differentiate
between conversion status. A similar distinction can be noticed between NL and NL converter
groups. We found significant differences between median time-shift for NL-NL converter,
MCI-MCI converter and MCI converter-AD (comparisons p < 0.01, Figure 12). It is also
important to recall that this result is obtained from the analysis of a single scan per imaging
modality and ADAS13 score for each patient.
5. Discussion
We presented a generative approach to spatio-temporal disease progression modeling based on
matrix factorization across temporal and spatial sources. The proposed application on a large
set of medical images shows the ability of the model to disentangle relevant spatio-temporal
processes at stake in AD, along with an estimated time-scale related to the disease evolution.
The model was compared to standard methods such as ICA, NMF and PCA since they
perform blind source separation similarly to our method. This allowed us to demonstrate
the advantages of building more complex approaches such as MGPA for the problem we
tackle in this work. Concerning the comparison with the state of the art in disease progres-
sion modelling, to the best of our knowledge the two closest approaches are [27] and [21].
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Figure 9: Model prediction averaged on specific brain areas (blue line), and observed values (red dots), along
the estimated time-line for the three imaging modalities. L and R respectively stand for left and right. The
time-scale was re-scaled to the arbitrary range [0, 1].
However, these two methods are specifically designed for modelling data defined on brain
surfaces. On the contrary, our method aims at progression modeling using full 3D volumet-
ric information. The data dimension we tackle is thus an order of magnitude greater than
the one of [27] and [21], preventing these methods to scale to the spatial geometry of our data.
There are several avenues of improvement for the proposed approach. We found that
the optimization is highly sensitive to the initialization of the spatial sources. This is typical
of such complex non-convex problems, and requires further investigations to better control
the algorithm convergence. More generally, the problem of source separation tackled in
this work is intrinsically ill-posed, as the given data can be explained by several solutions.
This was illustrated for example in our tests on synthetic data (Section 4.2), where the
identification of the sources was more challenging in the case of coarse resolution codes and
of flat temporal sources. We note however that this issue is general, and intrinsic to the
problem of disease progression modeling.
22
23
0.25 0.75
ADAS13 Evolution
Figure 10: Model prediction of the ADAS13 score (blue line), and observed values (red dots) along the
estimated time-line. The time-scale was re-scaled to the arbitrary range [0, 1].
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Figure 11: Evolution of the ADAS11 (left), FAQ (middle) and MMSE (right) along the estimated time-line.
The time-scale was re-scaled to the arbitrary range [0, 1].
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Figure 12: Distribution of the time-shift values over the different clinical stages. The time-scale was re-scaled
to the arbitrary range [0, 1].
Indeed, identifiability ultimately remains a critical issue when training the model. Concerning
the spatio-temporal parameters, their number is extremely high due to the fact that we scale
our method to 3D volumetric images. Estimating a single spatial source from a single modality
requires to estimate the mean and variance of its sparse code, i.e 1, 418, 820× 2 = 2, 837, 640
parameters. In practice, hypotheses are explicitly introduced to reduce the number of effective
parameters. For instance, the convolution of the spatial maps using Gaussian kernels allows
to enforce smoothness, and thus reduces the number of effective degrees of freedom via
spatial correlation across the related parameters. This is equivalent to the regularization
applied to image registration problems, in which the number of parameters is of the same
order of magnitude than in our setting. Moreover, our sparsity constraint allows to sensibly
reduce the number of parameters at test time. Indeed, after training, the sparse codes of
the MRI sources have 2, 213, 359 non-zero elements instead of 17, 025, 840, which amounts in
87% reduction in the number of parameters. In the case of the FDG-PET and AV45-PET
sparse codes, the number of non-zero elements at test time is respectively of 9, 023, 695 and
1, 362, 067, which is equivalent to a reduction in the number of parameters of 53% and 92%.
Nonetheless, this high number of parameters still remains a factor of potential convergence
issues during the parameters estimation procedure. We present graphs in Appendix F
showing the evolution of the different terms composing the cost function during training.
These figures show convergence profiles typical of those obtained with stochastic variational
inference schemes, such as with Variational Autoencoders or Bayesian Neural Networks.
Moreover, the stability of the solution has been ensured through multiple runs of the model.
Finally, as mentioned in Section 3.4, the Variational Dropout framework leads to stability
issues affecting inference, which are mostly due to the use of an improper prior. This prob-
lem may motivate the identification of alternative ways to induce sparsity on the spatial maps.
In this work, we modeled the time-shift of each subject as a translation with respect to a
common temporal reference. However, since pathological trajectories are different across indi-
viduals, it would be valuable to account for individual speed of progressions by introducing a
scaling effect, as it has been proposed for example in [21, 36]. This was not in the scope of the
current study, as we focused on the analysis of cross-sectional data, thus having only one data
point per subject. Therefore, one of the main extensions of this model will be the integration of
longitudinal data for each individual, which will allow a more specific time-reparameterization.
Our noise model for the reconstruction problem of Equation 2 is homoscedastic and i.i.d.
Gaussian with zero mean. For this reason, data variability for the entire image is encoded
by the variance parameter of the Gaussian noise. Similarly as in standard regression prob-
lems, this modelling choice has been motivated to promote simplicity of the model and
computational efficiency. However, around 40% of the values in the brain images do not
provide relevant information as they represent zero and constant background areas. For
this reason, during training, the model can perfectly fit this background and increases its
confidence on the overall regression solution, thus lowering the value of the noise variance
σm (cf Figure 9). This is in contrast to what we observe with the ADAS13 data (cf Figure
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10), where the problem corresponds to standard univariate regression. A potential way to fix
this issue could be to train the model only on non-zero image areas, or by implementing an
heteroscedastic noise model. However, this latter solution may further increase the number
of model parameters.
The modeling results are also sensitive to the specification of the spatio-temporal pro-
cesses priors. In our case, the monotonicity constraint imposed to the GPs may be too
restrictive to completely capture the complexity of the progression of neurodegeneration.
From a clinical point of view, the model could also benefit from the integration of data
measuring the concentration of Tau protein via PET imaging, in order to quantify key
neurobiological processes associated to AD [17].
In order to guarantee that all the subjects belong to the same pathological trajectory
due to AD, the model has only been applied to a cohort of amyloid positive subjects. How-
ever, this choice restricts the dynamics of evolution that we could estimate. Indeed, only
considering these subjects narrows down the time-line of the pathology, as we study patients
at potentially advanced disease stages. Therefore, it would be interesting in a future work
to apply the model on a cohort including amyloid negative subjects, to model the brain
dynamics over the whole disease natural history. This extension would require to define a
proper methodology for disentangling sub-trajectories associated, for example with normal
ageing and different pathological subtypes [24, 37, 40]. Moreover, we know that many patients
diagnosed with AD can be associated to mixed pathologies such as vascular disease or Lewy
bodies. Therefore, a potential clinical application of our method could be to investigate if
the spatio-temporal dynamics estimated by MGPA are able to disentangle the contribution
of each comorbidity.
Assessment of clinical plausibility of MGPA on the ADNI must be corroborated by further
validation on independent datasets. Therefore, in a future work, we wish to validate the
model on different cohorts to demonstrate its generalization properties. The validation step
for each subject would be done by estimating the time-point minimizing the cost between
the images of each tested individual, and the image progression model previously estimated
on ADNI. The estimated time-shift would provide a measure of the pathological stage of the
individual with respect to the modelled trajectory, and could be then compared with the
clinical diagnosis of the subject, allowing to test the reliability of our model. This additional
validation step could ultimately allow to use the model as a diagnostic instrument of AD.
This validation would require an important effort in terms of data harmonisation across
multiple cohorts, as well as in terms of clinical interpretation. For this reason, this work will
be part of a subsequent publication.
We planned to release the source-code along with instructions in order for the model
to be used by a large audience. It will be available as a complementary tool on the plat-
form http://gpprogressionmodel.inria.fr/, which already offers a simple front-end to
Gaussian Process Progression model.
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Appendix A.
In this Appendix, we detail the complete derivation of the lower bound.
log(p(Y m, Cm|Zm, δ, σm, γm)) = log
[ ∫
p(Y m|Bm,Sm,Zm, δ, σm)p(C|dS
m
dt
, δ, γm)p(B
m)
p(Sm,
dSm
dt
|δ, γ)dBmdSm
]
= log
[ ∫
p(Y m|Bm,Sm,Zm, δ, σm)p(C|dS
m
dt
, δ, γm)p(B
m)
p(
dSm
dt
|Sm, δ, γ)p(Sm)dBmdSm
]
.
By observing that dS
m
dt
is completely identified by Sm, the equation can be written as:
log(p(Y m, Cm|Zm, δ, σm, γm)) = log
[ ∫
p(Y m|Bm,Sm,Zm, δ, σm)p(C|dS
m
dt
, δ, γm)p(B
m)
p(Sm)dBmdSm
]
.
Similarly this derivation can be applied to log(p(V :c, Cc|δ, νc, γc)).
log(p(Y m, Cm|Zm, δ, σm, γm)) = log
[ ∫
p(Y m|Bm,Sm,Zm, δ, σm)p(C|dS
m
dt
, δ, γm)p(B
m)
p(Sm)dBmdSm
]
= log
[ ∫
p(Y m|Bm,Ωm,Wm,Zm, δ, σm)p(C|Ωm,Wm, δ, γm)p(Bm)
p(Ωm)p(Wm)dBmdΩmdWm
]
= log
[ ∫
p(Y m|Bm,Ωm,Wm,Zm, δ, σm)p(C|Ωm,Wm, δ, γm)p(Bm)
p(Ωm)p(Wm)
q1(B
m)q2(Ω
m)q3(W
m)
q1(B
m)q2(Ω
m)q3(W
m)
dBmdΩmdWm
]
= log
[
Eq1,q2,q3
p(Y m|Bm,Ωm,Wm,Zm, δ, σm)p(C|Ωm,Wm, δ, γm)
q1(B
m)q2(Ω
m)q3(W
m)
p(Bm)p(Ωm)p(Wm)
q1(B
m)q2(Ω
m)q3(W
m)
]
≥ Eq1,q2,q3
(
log
[p(Y m|Bm,Ωm,Wm,Zm, δ, σm)p(C|Ωm,Wm, δ, γm)
q1(B
m)q2(Ω
m)q3(W
m)
p(Bm)p(Ωm)p(Wm)
q1(B
m)q2(Ω
m)q3(W
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= Eq1,q2,q3 [log(p(Y m|Bm,Ωm,Wm,Zm, δ, σm))]
+ Eq2,q3 [log(p(Cm|Ωm,Wm, δ, γm))]
−D[q1(Bm)||p(Bm)]−D[q2(Ωm)||p(Ωm)]−D[q3(Wm)||p(Wm)].
This derivation gives us the lower bound Lm of a given modality m. The same technique
can be used to derive a lower bound for log(p(V c:, Cc|δ, νc, γc)), and by summation over m
and c we obtain the lower bound of Equation 10 for log(p(Y ,V , C|Z, δ, σ, ν, γ)).
Appendix B.
In this section we provide formulas for computing the three KL terms of the lower bound.
The total KL divergences are:
D[q1(B)||p(B)] =
∑
m
D[q1(Bm)||p(Bm)],
D[q2(Ω)||p(Ω)] =
∑
m
D[q1(Ωm)||p(Ωm)] +
∑
c
D[q1(Ωc)||p(Ωc)],
D[q3(W )||p(W )] =
∑
m
D[q3(Wm)||p(Wm)] +
∑
c
D[q3(W c)||p(W c)].
For ease of notation we will drop the m and c indices and will give formulas for a single
modality. In [29], authors provide an approximation of the KL for the maps B:
−D[q1(B)||p(B)] =
∑
n,f
k1h(k2 + k3 log(αn,f ))− 0.5 log(1 + α−1n,f )− k1,
where h is the sigmoid function and k1 = 0.63576, k2 = 1.87320, k3 = 1.48695.
In the case of Ω and W , we’ve seen that they have Gaussian priors and approximations
which are detailed in Sections 3.3.1 and 3.5. As a result we can obtain closed-form formulas
for their KL, leading to:
D[q2(Ω)|p(Ω)] = 1
2
∑
n,j
Q2n,jln +R
2
n,jln − 1− log(Q2n,jln),
D[q3(W )|p(W )] = 1
2
∑
n,j
V 2n,j + T
2
n,j − 1− log(V 2n,j).
By summation over the different modalities we finally obtain the total KL divergences.
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Appendix C.
We provide in this Appendix details for the experiments on real data.
• The number of random features for the GP estimation was set to 10, as it was enough
to recover the temporal sources in the synthetic experiments.
• The γ parameter controlling monotonicity was set to γm = 107 for each imaging
modality (Fm = 1, 418, 820 imaging features and Nm = 6 sources) and γc = 1 for
ADAS13 (Cc = 1 scalar feature).
• The lower bound was optimized using the ADAM optimizer [18].
• We used an alternate optimization scheme between the spatio-temporal parameters and
the time-shift of [2000, 1000] iterations repeated 20 times, followed by 30000 iterations
in which we only optimized the spatio-temporal parameters.
• The expectation terms in the lower bound were approximated using only one Monte-
Carlo sample as proposed in [20].
• The table below gives the learning rates (LR) of all the parameters of the model.
Table 1: Learning rates (LR) of the different parameters of the model.
θ M P Z σ, ν δ
lr 10−2 10−3 10−1 10−1 10−2 10−4
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Appendix D.
In this Appendix, we first provide a pseudo-code for sampling from a normal distribution
using the reparameterization trick (see Algorithm 1). The second pseudo-code (Algorithm 2)
details the steps to compute the lower bound Lm for a given imaging modality m. We recall
that we want to optimize the following sets of parameters (see Section 3.5): δ = {δp}Pp=0,
Z, σ = {σm}Mm=1, ν = {νc}Cc=1, θ = {θm}Mm=1 ∪ {θc}Cc=1, and ψ = {ψm}Mm=1. Where P is the
number of subjects, M the number of imaging modalities, C the number of scalar features,
and Nm the number of spatio-temporal sources for a given modality m.
θ = {Rmn:,Qmn:,Tmn:,V mn:, ln, n ∈ [1, Nm]}Mm=1 ∪ {Rc:,Qc:,T c:,V c:, lc, }Cc=1,
ψ = {Mmn:,Pmn:, n ∈ [1, Nm]}Mm=1.
(1)
Similarly to Algorithm 2, we can derive a function LOSS SCALAR when dealing with scalar
scores by removing the computations on the spatial sources. Finally the last pseudo-code
(Algorithm 3) details the model optimization. For sake of clarity we denote by Π, the set of
all the spatio-temporal parameters of the model.
Algorithm 1 Sampling from N (µ,Σ) using the reparameterization trick.
1: function RT(µ,Σ)
2: ← random sample from N (0, I)
3: z = µ+ Σ
1
2 . Gives one sample from N (µ,Σ)
4: Return z
5: end function
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Algorithm 2 Compute loss for a given imaging modality m.
1: function loss image(Y m, θm, ψm,Z
m, σm, δ, γm, Nm, Fm, P )
For ease of notation we drop the m index in the pseudo-code.
2: for n=1 to N do . For each source
3: Bn: = RT(Mn:, diag(P n,:)) . Sampling from q1
4: ωn = RT(Rn:, diag(Q
2
n:)) . Sampling from q2
5: wn = RT(T n:, diag(V
2
n:)) . Sampling from q3
6: An: = Bn:Σ
n . Convolution of the sparse code of source n at a given spatial
resolution
7: S:n(δ) = φ(δ(ω
n)T )wn . Compute temporal trajectory of source n
8: S′:n(δ) =
dφ(δ(ωn)T )
dδ
wn . Compute derivative of temporal trajectory of source n
9: end for
10: Ω← block diagonal matrix containing all the set of (ωn)T
11: W ← block diagonal matrix containing all the set of wn
12: Eq1,q2,q3 [log(p(Y |B,Ω,W ,Z, δ, σ))] ≈
∑
p−F2 log(2piσ2)− 12σ2 ||Y p: − Sp:A−Zp:||2
13: Eq2,q3 [log(p(C|Ω,W , δ, γ))] ≈ −
∑
p,n log((1 + exp(−γS′p,n(δ)))
. The two expectations terms are approximated using only one Monte-Carlo sample
as proposed in [20].
14: KL = D[q1(B)||p(B)] +D[q2(Ω)||p(Ω)] +D[q3(W )||p(W )] . This tern is computed
using approximations and formulas of Appendix B.
15: L = Eq1,q2,q3 [log(p(Y |B,Ω,W ,Z, δ, σ))] + Eq2,q3 [log(p(C|Ω,W , δ, γ))]−KL
16: Return L
17: end function
35
Algorithm 3 Model optimization.
1: function optimize(Y ,V ,Π, δ, n iter0, n iter1, n iter2)
2: Initialize Π(0), δ(0)
3: i, j, k = 0
4: while i ≤ n iter0 do
5: for l=1 to n iter1 do . Optimizing spatio-temporal parameters only
6: L = 0
7: for m=1 to M do . For each modality
8: L += LOSS IMAGE(Y m, θm, ψm,Zm, σm, δ, γm, Nm, Fm, P )
9: end for
10: for c=1 to C do . For each scalar feature
11: L += LOSS SCALAR(V :c, θc, νc, δ, γm, P )
12: end for
13: Compute dL
dΠ(j)
through backpropagation
14: Π(j+1) = ADAM( dL
dΠ(j)
,Π(j),LR(Π)) . The spatio-temporal parameters are
optimized by gradient descent using the ADAM optimizer. LR refers to the overall set of
learning rates (cf Appendix C.)
15: j += 1
16: end for
17: for l=1 to n iter2 do . Optimizing time-shift only
18: L = 0
19: for m=1 to M do
20: L += LOSS IMAGE(Y m, θm, ψm,Zm, σm, δ, γc, Nm, Fm, P )
21: end for
22: for c=1 to C do
23: L += LOSS SCALAR(V :c, θc, νc, δ, γc, P )
24: end for
25: Compute dL
dδ(k)
through backpropagation
26: δ(k+1) = ADAM( dL
dδ(k)
, δ(k),LR(δ))
27: k += 1
28: end for
29: i += 1
30: end while
31: end function
Appendix E.
In this Appendix, we show results obtained with standard methods (ICA, NMF, PCA) when
applied within the experimental setting of Section 4.2. We recall that for these experiments
observations were randomly aligned along the time-axis. The goal was to assess the ability
of the different methods to reconstruct the spatio-temporal sources underlying the data
when the time-axis is unknown. Results obtained in Table 1 show a substantial decrease
of performances for the MSE and SSIM compared to MGPA (cf Table 2 in Section 4.2).
Indeed, these methods do not consider time as a variable on which inference is required,
thus preventing them from reconstructing correctly the temporal sources. Figure 1 shows
an example of reconstruction when using ICA. We observe that even though the spatial
reconstruction remains acceptable, the estimated temporal sources are not interpretable as
ICA reconstructs the data using the time-axis on which observations have been mixed.
Table 1: MSE and SSIM between respectively the ground truth temporal and spatial sources with respect to
the ones estimated by the different standard methods.
Temporal (MSE) Spatial (SSIM)
ICA 0.24± 0.08 54%± 2
NMF 0.25± 0.03 22%± 14
PCA 0.66± 0.05 9%± 3
Ground Truth ICA maps S0
0 21
Maps Intensity
Spatial maps Temporal sources
S1
A0
A1
ICA
Original Time
ICA
Figure 1: Spatial maps: Sample slice from ground truth images (A0 λ = 2 mm, A1 λ = 1 mm), the maps
estimated by ICA. Temporal sources: Ground truth temporal sources (red) along with sources estimated by
ICA (blue).
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Appendix F.
We provide in this Appendix details on the model convergence when applied on the ADNI
data. The training was divided in three iterations of 30000 epochs each. During the
two first iterations the spatio-temporal parameters and the time-shift are trained alter-
natively following a scheme of [2000,1000] epochs ten times. The third iteration only
optimizes the spatio-temporal parameters. In Figure 1, we show the evolution of the
total loss and the different terms composing it during training. The term reconstruc-
tion cost stands for
∑
m Eq1,q2,q3 [log(p(Y
m|Bm,Ωm,Wm,Zm, δ, σm))], monotonicity cost for∑
m Eq2,q3 [log(p(Cm|Ωm,Wm, δ, γm))] and KL for
∑
mD[q1(Bm)||p(Bm)]+D[q2(Ωm)||p(Ωm)]+
D[q3(Wm)||p(Wm)]. We observe that through the first two iterations the reconstruction
and monotonicity costs decrease, and become stable during the last iteration. Differently,
the KL cost increases during the first iteration as the model is driven by the reconstruction
and monotonicity constraints. The KL term decreases during the second iteration, thus
regularizing the model, before becoming stable during the third iteration. We also note that
the graphs in Figure 1 show convergence profiles typical of those obtained with stochastic
variational inference schemes, such as with Variational Autoencoders or Bayesian Neural
Networks.
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Figure 1: Evolution of the total loss, reconstruction cost, monotonicity cost and KL during training. Each
iteration corresponds to 30000 epochs.
Appendix G.
In this Appendix, we provide the results obtained when applying ICA, NMF and PCA on
the ADNI data of Section 4.3.1. We used the three imaging modalities for each subject
and concatenated these images in a (544× 4256460) matrix. Our goal was to compare the
spatio-temporal processes extracted using these standard methods with the ones from MGPA.
We recall that in the case of MGPA the model automatically re-aligns the observations
following monotonic assumptions for each biomarker, while these standard methods don’t
perform any inference on the time variable. Therefore, we created three experimental settings
in which we changed the observations’ alignment. In the first one, subjects were aligned by
their chronological age (Figures 1, 2 and 3), in the second one by ADAS13 (Figures 4, 5 and
6) and in the last one time was randomly initialized like in the experiments of Section 4.3.3
(Figures 7, 8 and 9). We extracted six spatio-temporal sources for each method and each
time-alignment, like in 4.3.2.
We observe that the temporal profiles are generally noisy and hard to interpret due to
the lack of constraints on the temporal evolution. This motivates the need of smooth and
monotonic constraints as in MGPA. Moreover, due to the concatenation of all the modalities
they all share the same temporal patterns. This is an important difference with the modality-
specific modelling of MGPA. Finally, we note that the spatial patterns associated with each
method are very similar, independently from the time-initialization, while the temporal
sources substantially differ. This is also true when time is randomly initialized. These
observations point to the challenge of giving a clinical interpretation of the results obtained
with these approaches, and therefore to the need of plausible spatio-temporal constraints as
provided in MGPA.
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Subjects aligned by age.
40
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Figure 1: Spatio-temporal processes extracted by ICA with subjects aligned by age.
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Figure 2: Spatio-temporal processes extracted by NMF with subjects aligned by age.
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Figure 3: Spatio-temporal processes extracted by PCA with subjects aligned by age.
Subjects aligned by ADAS13.
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Figure 4: Spatio-temporal processes extracted by ICA with subjects aligned by ADAS13.
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Figure 5: Spatio-temporal processes extracted by NMF with subjects aligned by ADAS13.
47
Figure 6: Spatio-temporal processes extracted by PCA with subjects aligned by ADAS13.
Subjects randomly aligned.
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Figure 7: Spatio-temporal processes extracted by ICA with subjects randomly aligned.
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Figure 8: Spatio-temporal processes extracted by NMF with subjects randomly aligned.
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Figure 9: Spatio-temporal processes extracted by PCA with subjects randomly aligned.
